BriaCell Therapeutics Corp.

NASDAQ: BCTX · Healthcare · Biotechnology

Canadian filerHQ West Vancouver, BCCIK 0001610820Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 30DQ —GM —SS 47

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, listing tenure · ↓ Piotroski F, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$26.3M

Employees

Market cap

$6.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$26.3M-$26.3M2025

Operating income-$27.2M-$27.2M2025

Total assets$21.6M$21.6M2025

Equity$17.3M$17.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BriaCell Therapeutics Corp. earned -$26.3M in FY2025 net income.

Peers · Healthcare

Curative Biotechnology, Inc.——Eastgate Biotech Corp.——Nextleaf Solutions Ltd.57C Mid-Atlantic Home Health Network, Inc.——

Key facts

CEOWilliam V. Williams

SectorHealthcare

IndustryBiotechnology

HeadquartersWest Vancouver, BC

ExchangeNASDAQ: BCTX

Employees16

IPO date2012-03-14

Latest filings

8-K2026-06-26 10-Q2026-06-09 8-K2026-06-03 8-K2026-03-31 10-Q2026-03-10 8-K2026-03-09 8-K2026-02-20 DEF 14A2026-02-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.